We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-13.89%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$744M
AUM Growth
-$81.5M
Cap. Flow
+$46.5M
Cap. Flow %
6.24%
Top 10 Hldgs %
31.55%
Holding
2,869
New
240
Increased
1,414
Reduced
721
Closed
181

Sector Composition

Rank Sector Weight
1 Technology 12.36%
2 Healthcare 7.65%
3 Financials 6.69%
4 Consumer Staples 6.68%
5 Consumer Discretionary 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$382B
$4.81M 0.65%
9,369
+386
+4% +$194K
JNJ icon
27
Johnson & Johnson
JNJ
$635B
$4.74M 0.64%
26,721
+934
+4% +$166K
IWB icon
28
iShares Russell 1000 ETF
IWB
$47.7B
$4.72M 0.63%
22,706
+2,053
+10% +$464K
BRK.B icon
29
Berkshire Hathaway Class B
BRK.B
$1.07T
$4.2M 0.56%
15,387
+51
+0.3% +$16K
JPM icon
30
JPMorgan Chase
JPM
$939B
$3.87M 0.52%
34,383
+1,673
+5% +$207K
IWF icon
31
iShares Russell 1000 Growth ETF
IWF
$122B
$3.72M 0.5%
68,080
-32
-0% -$1.92K
ISTB icon
32
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.08B
$3.6M 0.48%
75,902
+75,579
+23,399% +$3.61M
VNQ icon
33
Vanguard Real Estate ETF
VNQ
$39.9B
$3.56M 0.48%
39,080
-11,677
-23% -$1.16M
HD icon
34
Home Depot
HD
$332B
$3.47M 0.47%
12,665
+241
+2% +$71.2K
ABBV icon
35
AbbVie
ABBV
$458B
$3.39M 0.46%
22,144
-66
-0.3% -$10.1K
PFE icon
36
Pfizer
PFE
$140B
$3.39M 0.46%
64,695
-2,298
-3% -$117K
ABT icon
37
Abbott
ABT
$180B
$3.38M 0.45%
31,094
-95
-0.3% -$10.8K
HI
38
DELISTED
Hillenbrand
HI
$3.28M 0.44%
79,977
+130
+0.2% +$5.43K
EFA icon
39
iShares MSCI EAFE ETF
EFA
$76.4B
$3.27M 0.44%
52,294
+547
+1% +$37.2K
SCHF icon
40
Schwab International Equity ETF
SCHF
$65.6B
$3.26M 0.44%
207,582
+139,188
+204% +$2.37M
IWO icon
41
iShares Russell 2000 Growth ETF
IWO
$14.5B
$3.25M 0.44%
15,737
GOOG icon
42
Alphabet (Google) Class C
GOOG
$3.9T
$3.17M 0.43%
29,020
-680
-2% -$80.3K
XOM icon
43
ExxonMobil
XOM
$651B
$3.01M 0.4%
35,198
+1,416
+4% +$128K
PEP icon
44
PepsiCo
PEP
$186B
$2.82M 0.38%
16,935
+740
+5% +$125K
IWR icon
45
iShares Russell Mid-Cap ETF
IWR
$56.8B
$2.66M 0.36%
41,167
-400
-1% -$28.5K
LLY icon
46
Eli Lilly
LLY
$1.07T
$2.6M 0.35%
8,022
+414
+5% +$124K
NVDA icon
47
NVIDIA
NVDA
$5.01T
$2.47M 0.33%
163,100
+10,190
+7% +$192K
V icon
48
Visa
V
$677B
$2.46M 0.33%
12,477
+437
+4% +$90.3K
TMO icon
49
Thermo Fisher Scientific
TMO
$211B
$2.45M 0.33%
4,506
+9
+0.2% +$4.95K
ORCL icon
50
Oracle
ORCL
$331B
$2.42M 0.33%
34,650
+300
+0.9% +$22K

Similar funds

Quadrant Capital Group's Q2 2022 Portfolio in Review

As of Q2 2022, Quadrant Capital Group held 2,869 positions worth $744M, down 9.9% from $826M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Quadrant Capital Group deployed $46.5M of net new capital in Q2 2022, opening 240 new positions and adding to 1,414 existing holdings. Its largest new stake was Vanguard Intermediate-Term Bond ETF: 21,020 shares worth $1.63M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $4.02M trimmed.

  • Quadrant Capital Group's largest Q2 2022 buy was Vanguard Intermediate-Term Bond ETF: 21,020 shares worth $1.63M.
  • Quadrant Capital Group added most to iShares Core MSCI EAFE ETF in Q2 2022, an estimated $7.4M increase.
  • Quadrant Capital Group's biggest Q2 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $4.02M.
  • Quadrant Capital Group fully exited RiverNorth Opportunistic Municipal Income Fund in Q2 2022, selling an estimated $900K.
  • Quadrant Capital Group's ten largest holdings make up 32% of its $744M portfolio in Q2 2022.
  • Quadrant Capital Group opened 240 new positions and closed 181 in Q2 2022.
  • Quadrant Capital Group's portfolio value fell 9.9% quarter-over-quarter to $744M.

Based on Quadrant Capital Group's 13F filing for Q2 2022, filed 9 Aug 2022.